/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

ImmuCell Corp

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$5.283 0.05(5%) ICCC at 04 Dec 2025 04:34 PM Biotechnology
Lowest Today 4.99
Highest Today 5.38
Today’s Open 4.99
Prev. Close 5
52 Week High 7.60
52 Week Low 4.28
Day’s Range: Low 4.99 High 5.38
52-Week Range: Low 4.28 High 7.60
1 day return -
1 Week return -
1 month return -22.76
3 month return -22.88
6 month return -26.01
1 year return -3.65
3 year return -31.65
5 year return -20.83
10 year return -

Institutional Holdings

Vanguard Group Inc 3.41

Vanguard Total Stock Mkt Idx Inv 2.00

Renaissance Technologies Corp 1.77

Cresset Asset Management, LLC 1.46

Morgan Stanley - Brokerage Accounts 1.16

Bleichroeder LP 1.12

Dauntless Investment Group, LLC 1.05

Vanguard Institutional Extnd Mkt Idx Tr 0.94

Geode Capital Management, LLC 0.79

Dimensional Fund Advisors, Inc. 0.77

Shufro Rose & CO LLC 0.67

Northern Trust Corp 0.47

Citadel Advisors Llc 0.45

Fidelity Extended Market Index 0.39

Strategic Investment Advisors Inc 0.34

HighTower Advisors, LLC 0.24

DFA US Core Equity 2 I 0.20

Prosperity Planning, Inc. 0.18

BlackRock Inc 0.17

DFA US Targeted Value I 0.17

iShares Micro-Cap ETF 0.15

Fidelity Total Market Index 0.15

Mesirow Fin Investmt Mgmt Intl Equity 0.13

Dimensional US Targeted Value ETF 0.12

Essex Financial Services, Inc. 0.12

Fidelity Series Total Market Index 0.10

UBS Group AG 0.09

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - NL 0.04

HM Payson & Co 0.04

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

Spartan Total Market Index Pool G 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

DFA US Vector Equity I 0.03

DFA US Core Equity Class F 0.03

DFA US Social Core Equity 2 Portfolio 0.02

Bank of America Corp 0.02

Fidelity Nasdaq Composite Index 0.02

Northern Small Cap Core I 0.02

Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 54.73 M

PB Ratio 1.4388

PE Ratio 28.8095

Enterprise Value 52.60 M

Total Assets 45.10 M

Volume 8447

Company Financials

Annual Revenue FY23:16286588 16.3M, FY22:18568000 18.6M, FY21:19243000 19.2M, FY20:15342000 15.3M, FY19:13723000 13.7M

Annual Profit FY23:3603720 3.6M, FY22:7649000 7.6M, FY21:8656000 8.7M, FY20:6863000 6.9M, FY19:6740000 6.7M

Annual Net worth FY23:-6302633 -6.3M, FY22:-2494000 -2.5M, FY21:-78000 -0.1M, FY20:-1022000 -1.0M, FY19:-1296000 -1.3M

Quarterly Revenue Q3/2025:5506122 5.5M, Q2/2025:6444880 6.4M, Q1/2025:8067174 8.1M, Q3/2024:6011573000 6011.6M, Q2/2024:5472890 5.5M

Quarterly Profit Q3/2025:2363098 2.4M, Q2/2025:2817924 2.8M, Q1/2025:3353972 3.4M, Q3/2024:1583554000 1583.6M, Q2/2024:1230486 1.2M

Quarterly Net worth Q3/2025:-139748 -0.1M, Q2/2025:501880 0.5M, Q1/2025:1446983 1.4M, Q3/2024:-701690000 -701.7M, Q2/2024:-1531626 -1.5M

Fund house & investment objective

Company Information ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Organisation Biotechnology

Employees 77

Industry Biotechnology

CEO Mr. Michael F. Brigham

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow